Boston Scientific

As the global market leader in peripheral interventions, Boston Scientific offers the broadest portfolio of solutions for treating peripheral artery disease (PAD) and deep vein thrombosis (DVT). We are also focused on our Interventional Oncology portfolio, enabling physicians to minimally invasively treat tumors by delivering targeted and localized embolic and ablative technologies. We’re dedicated to developing technologies that improve outcomes, cut costs and—most importantly—help physicians to save the lives and limbs of more people in more places around the world.